drugset / Trial / NCT02275468

Fu-zheng-qu-zhuo Oral Liquid Improves Renal Function in Patients of CKD Stage 3 and 4

NCT02275468 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

a prospective, multicenter (outpatient clinics of the three participating hospitals in Beijing), double blinded and randomized placebo-controlled study. The study consisted of a 2-week run-in period and a 12-month treatment period.

Timeline

Start
2010-06
Primary completion
2013-05
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Fu-zheng-qu-zhuo Unknown 20 ml Oral